go to main content
Radboud Institute for Health Sciences Organization Research groups
Overview of research groups connected to RIHS. You can filter the list with regard to keywords, research themes and research departments.
Results (37)

Filter results

Bacteriology

Heiman Wertheim's research group is primarily focused on the diagnostics of bacterial infections and antibiotic resistance.

Biostatistics

Kit Roes's research group aims to continuously improve the quality of medical research, by applying, teaching and developing statistical methods and statistical thinking, aiming for broad use by researchers.

Cancer epidemiology

Bart Kiemeney's research group learns as much as possible about cancer with the aim of reducing the burden of this disease. The emphasis lies on the detection of urological tumours and their genetic causes.

Cancer screening and follow-up

Mireille Broeders's research (sub)group looks at whether there’s value to be gained in targeting the screening or follow-up policy to a person’s level of risk, by collecting information on risk factors from screening participants and patients.

Cardiovascular physiology and exercise

Dick Thijssen's research group focuses on the field of cardiovascular physiology and physical (in)activity. His work strongly focuses on understanding the impact of exercise training and physical activity on reducing the risk of developing cardiovascular and metabolic diseases.

Cerebral perfusion in neurosurgery

Jurgen Fütterer's and Mark ter Laan's research group explores the feasibility and diagnostic accuracy of cerebral perfusion imaging in neurosurgery. We compare several techniques, and develop new applications for cerebral perfusion imaging in the Hybrid-OR.

Clinical pharmacology

Nielka van Erp's research group aims to optimize anticancer treatment in oncology patients by recognizing and addressing interindividual differences and by developing approaches to keep the drugs available for all patients suffering from cancer.

Clinical pharmacology - special populations

Saskia de Wildt's research group uses innovative methods including microdosing and microtracer technology, and physiology-based and population pharmacokinetic modeling, to contribute to a better understanding of the impact of age, disease and genetics on drug disposition in children.

Computational pathology group

Jeroen van der Laak's research group develops, validates and deploys novel medical image analysis methods based on deep learning technology and focusing on computer-aided diagnosis.

Elderly care medicine

Raymond Koopmans's research group focusses on research on people with dementia or neurological disorders.

Evidence based surgery

Maroeska Rovers's research (sub)group investigates which surgical techniques are being used and whether or not they are necessary.

Exercise physiology

Thijs Eijsvogels’s research group studies the acute and long-term effects of exercise on health. Current projects involve cardiac imaging following lifelong exercise training, optimizing cardiac rehab, assessing thermoregulatory responses in elite athletes and development of cooling strategies.

Global health priorities

Rob Baltussen's research (sub)group supports decision-makers in countries around the world in setting legitimate priorities for universal health coverage.

Health technology assessment

Gert Jan van der Wilt's research group conducts research into the effectiveness, safety, efficiency and social acceptability of medical technology.

HTA business

Maroeska Rovers's research (sub)group aims to guide new medical technology innovations by facilitating partnerships between the scientific community, medical technology business partners and policy makers.

Human papillomaviruses (HPV)

Willem Melchers's research aims to improve the nationwide cervical cancer screening, with the possibility of using self sampling. Important herein is research on the use of new triage methods for hrHPV positive women, by using HPV genotyping or molecular biomarkers.

Intellectual disability & health

Geraline Leusink's research group has the mission to improve the health and healthcare for people with ID by integrating research, education and patient care.

Meaningful healthcare

Yvonne Engels's research group focuses on optimizing the quality of life of patients, including existential, physical, social and psychological needs.

Medication safety

Cornelis (Kees) Kramers's research group aims to improve medication safety by education of prescribers, transmural interventions and medication optimization.

MRI-guided RFA therapy of liver and pancreatic tumors

Jurgen Fütterer's, Martijn Stommel's and Kristian Overduin's research group aims to assess the feasibility of real-time MRI temperature monitoring and ablation zone assessment during RFA of liver and pancreatic tumors.

MRI-guided Transurethral UltraSound Ablation

Jurgen Fütterer's research group performs MRI-guided Transurethral UltraSound Ablation (TULSA) in the prostate.

Mycobacterio­logy

Jakko van Ingen's research group aims to improve the outcomes of antibiotic treatment of NTM disease.

Orthopaedic research lab

Nico Verdonschot's research group focuses on the external loads applied to the musculoskeletal system, and how these loads influence the reconstructions.

Personalized pharmaceutical care

Bart van den Bemt's research group is a (inter)nationally recognized group on adequate medication use, medication adherence, medication waste and (cost-)effective pharmacotherapy.

Pharmaco­genomics

Marieke Coenen's research group performs pharmacogenetic research, from gene-finding to clinical implementation studies with a focus on paediatric (oncology) and psychiatry and inflammatory bowel disease.

Pharmacology of antibiotic agents

Roger Brüggemann's and Nynke Jager's research group investigates the pharmacokinetics and dynamics of antimicrobial agents. Research ranges from in vitro experiments to clinical trials in special patient populations. The main aim is to define the optimal dose for each individual patient.

Pharmacology of anti-tuberculosis drugs

Rob Aarnoutse's research group investigates the pharmacology of existing and new drugs for tuberculosis, using a translational approach that extends from molecular pharmacology to clinical pharmacology studies and to clinical trials, supported by advanced laboratory and modeling techniques.

Pharmacology of antiviral drugs (HIV and HCV)

David Burger's group investigates the pharmacology of antiviral drugs for the treatment of HIV and hepatitis C in special patient population such as pregnant women, children and hepatically impaired patients. We also study drug-drug interactions and the impact on exposure of new drug-formulations.

Plastic surgery research & Innovation lab

Dietmar Ulrich's research group is continuously aiming to find the latest and best methods to treat patients that visit the department of Plastic Surgery.

Quality and safety of oral healthcare

Stefan Listl's research group seeks to increase the value for money in health and dental care by gaining knowledge and improving the implementation of evidence-informed strategies in health policy and daily dental practice.

Radboud applied pharmacome­trics

Rob ter Heine's and Elin Svensson's research group develops and applies mathematical models describing clinical pharmacology processes to interpret clinical trial data, perform clinical trial simulations, support drug development decisions, and optimize therapy in the clinic.

Reproductive epidemiology

Nel Roeleveld's research group investigates all aspects of human reproduction. The primary question underlying our research is: how can we prevent something from going wrong before, during or after pregnancy?

Research in primary care

Pim Assendelft's research group aims to improve healthcare, from a primary care and transmural perspective.

Risk assessment and molecular epidemiology

Paul Scheepers's research (sub)group investigates how we can stay healthy and which environmental factors affect our health.

Translational cardiovascular research

Gerard Rongen's research group studies the impact of nucleoside transport inhibitors on vascular actions of adenosine and ischemia reperfusion injury.

Translational CRC research

Daniele Tauriello's, Henk Verheul's, Nielka van Erp's and Iris Nagtegaal's research group is a cross-disciplinary research collaboration of four Radboudumc groups, with the aim of advancing clinical translation for colorectal cancer.

Tuberculosis: From basic biology to population control

Reinout van Crevel's research group integrates patient studies and laboratory sciences to understand the biology of tuberculosis (TB) transmission, infection and disease, including its severest form: meningitis.